← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 16, 2019Last known activity
Jun 23, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT06844500CollaboratorPhase 3Jun 23, 2025
- NCT06844487CollaboratorPhase 3May 29, 2025
- NCT04186000CollaboratorPhase 2Dec 16, 2019
Details
- Last known activity
- Jun 23, 2025